Form 4: ACTUATE THERAPEUTICS Director and 10% Owner Aaron Fletcher Granted 15,000 Stock Options
Insider Transaction Report
Aaron G.L. Fletcher, a Director and 10% owner of Actuate Therapeutics, Inc., was granted 15,000 stock options with an exercise price of $10.10, vesting on the anniversary of the grant date.
Summary
- Aaron G.L. Fletcher, a Director and 10% owner of Actuate Therapeutics, Inc. (ACTU), acquired 15,000 stock options on May 22, 2025.
- Each option has an exercise price of $10.10.
- The options will vest in full on the anniversary of the grant date, meaning they will become fully exercisable on May 22, 2026.
- The options have an expiration date of May 22, 2035.
- Following this transaction, Mr. Fletcher directly beneficially owns 15,000 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The grant of stock options to a director and significant owner is generally a positive signal of alignment with long-term company performance, though it's a routine compensation event rather than a major strategic announcement.
Positives
- The grant of stock options to a Director and 10% owner, Aaron G.L. Fletcher, aligns his interests with long-term shareholder value creation.
- The options have a 10-year expiration period (until May 22, 2035), providing a long-term incentive for the executive.
Negatives
- The options vest on the anniversary of the grant date, meaning the full benefit is not immediately realized upon grant.
Future Outlook
N/A
Industry Context
N/A
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Aaron G.L. Fletcher granted a Power of Attorney to Paul Lytle, Janis Penman, Janet Spreen, Brittany Stevenson, and Michael Gunther to execute SEC filings on his behalf. | 06/13/2024 | Streamlines the process for the reporting person to comply with SEC filing requirements, ensuring timely and accurate disclosures. |
Stakeholder Impact
- Shareholders: The grant of options to a director and 10% owner aligns their interests with shareholder value creation, as the options gain value if the stock price increases.
Next Steps
- The granted stock options are scheduled to vest in full on May 22, 2026, which is the anniversary of the grant date.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date Power of Attorney was executed by Aaron G.L. Fletcher. |
| 05/22/2025 | Transaction date for the acquisition of 15,000 stock options by Aaron G.L. Fletcher (Grant Date). |
| 05/23/2025 | Signature date of the Form 4 filing by Paul Lytle, Attorney-in-Fact. |
| 05/22/2026 | Date the stock options are scheduled to vest in full (anniversary of grant date). |
| 05/22/2035 | Expiration date of the granted stock options. |
Recommendation
holdKeywords
ACTUATE THERAPEUTICS, ACTU, SEC Form 4, Stock Options, Insider Trading, Director Compensation, Equity Grant, Beneficial Ownership, Aaron G.L. Fletcher
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.